Gene · 84433
Papers2,534
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
361 to 380 of 2,534
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Plasma cell neoplasms and related entities-evolution in diagnosis and classification. | Virchows Arch | 2023 | 36414803 | PubTator, text mining | PubMed |
| Frequent Gene Mutations and Their Possible Roles in the Pathogenesis, Treatment and Prognosis of Primary Central Nervous System Lymphoma. | World Neurosurg | 2023 | 36396049 | PubTator, text mining | PubMed |
| Follicular lymphoma and marginal zone lymphoma: how many diseases? | Virchows Arch | 2023 | 36394631 | PubTator, text mining | PubMed |
| mTOR inhibition amplifies the anti-lymphoma effect of PI3Kβ/δ blockage in diffuse large B-cell lymphoma. | Leukemia | 2023 | 36352190 | PubTator, text mining | PubMed |
| Genomic Profiling Reveals Differences in Primary Central Nervous System Lymphoma and Large B-Cell Lymphoma, With Subtyping Suggesting Sensitivity to BTK Inhibition. | Oncologist | 2023 | 36342081 | PubTator, text mining | PubMed |
| From thymus to tissues and tumors: A review of T-cell biology. | J Allergy Clin Immunol | 2023 | 36272581 | PubTator, text mining | PubMed |
| Evaluation of 4 prognostic indices in follicular lymphoma treated in first line with immunochemotherapy. | Blood Adv | 2023 | 36260737 | PubTator, text mining | PubMed |
| Intravascular Large B-Cell Lymphoma Genomic Profile Is Characterized by Alterations in Genes Regulating NF-κB and Immune Checkpoints. | Am J Surg Pathol | 2023 | 36221796 | PubTator, text mining | PubMed |
| Disease-Defining Molecular Features of Primary Cutaneous B-Cell Lymphomas: Implications for Classification and Treatment. | J Invest Dermatol | 2023 | 36163302 | PubTator, text mining | PubMed |
| Transcriptomic clustering of critically ill COVID-19 patients. | Eur Respir J | 2023 | 36104291 | PubTator, text mining | PubMed |
| Resistance to Bruton tyrosine kinase inhibition in chronic lymphocytic leukaemia and non-Hodgkin lymphoma. | Br J Haematol | 2023 | 36029036 | PubTator, text mining | PubMed |
| Autophagy-associated immune dysregulation and hyperplasia in a patient with compound heterozygous mutations in ATG9A. | Autophagy | 2023 | 35838483 | PubTator, text mining | PubMed |
| The Treatment of Primary Immune Deficiencies: Lessons Learned and Future Opportunities. | Clin Rev Allergy Immunol | 2023 | 35776401 | PubTator, text mining | PubMed |
| Very-Early Onset Chronic Active Colitis with Heterozygous Variants in LRBA1 and CARD11, a Case of "Immune TOR-Opathies". | Fetal Pediatr Pathol | 2023 | 35748740 | PubTator, text mining | PubMed |
| Construction of ovarian metastasis-related immune signature predicting prognosis of gastric cancer patients. | Cancer Med | 2023 | 35621244 | PubTator, text mining | PubMed |
| Pediatric Evans Syndrome: A 20-year experience from a tertiary center in Brazil. | Hematol Transfus Cell Ther | 2023 | 35256332 | PubTator, text mining | PubMed |
| Circulating Tumor DNA-Based Genotyping and Monitoring for Predicting Disease Relapses of Patients with Peripheral T-Cell Lymphomas. | Cancer Res Treat | 2023 | 35240014 | PubTator, text mining | PubMed |
| Case report: 7p22.3 deletion and 8q24.3 duplication in a patient with epilepsy and psychomotor delay-Does both possibly act to modulate a candidate gene region for the patient's phenotype? | Front Genet | 2022 | 36778913 | PubTator, text mining | PubMed |
| Etiopathogenesis of Psoriasis from Genetic Perspective: An updated Review. | Curr Genomics | 2022 | 36777004 | PubTator, text mining | PubMed |
| Skin manifestations of inborn errors of NF-κB. | Front Pediatr | 2022 | 36733767 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/84433/papers?page=19